Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of EUR 236.87 billion. The enterprise value is 272.04 billion.

Market Cap	236.87B
Enterprise Value	272.04B

Important Dates

The last earnings date was Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	Mar 10, 2026

Share Statistics

Current Share Class	1.91B
Shares Outstanding	n/a
Shares Change (YoY)	-3.80%
Shares Change (QoQ)	-0.67%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	43.83%
Float	1.82B

Valuation Ratios

The trailing PE ratio is 20.18 and the forward PE ratio is 16.19.

PE Ratio	20.18
Forward PE	16.19
PS Ratio	4.83
PB Ratio	7.02
P/TBV Ratio	n/a
P/FCF Ratio	15.58
P/OCF Ratio	14.24
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.51, with an EV/FCF ratio of 17.89.

EV / Earnings	23.18
EV / Sales	5.54
EV / EBITDA	13.51
EV / EBIT	17.02
EV / FCF	17.89

Financial Position

The company has a current ratio of 0.85, with a Debt / Equity ratio of 1.21.

Current Ratio	0.85
Quick Ratio	0.53
Debt / Equity	1.21
Debt / EBITDA	2.03
Debt / FCF	2.68
Interest Coverage	15.14

Financial Efficiency

Return on equity (ROE) is 34.93% and return on invested capital (ROIC) is 21.10%.

Return on Equity (ROE)	34.93%
Return on Assets (ROA)	10.54%
Return on Invested Capital (ROIC)	21.10%
Return on Capital Employed (ROCE)	21.14%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	651,947
Profits Per Employee	155,952
Employee Count	75,267
Asset Turnover	0.52
Inventory Turnover	2.28

Taxes

In the past 12 months, Novartis AG has paid 1.97 billion in taxes.

Income Tax	1.97B
Effective Tax Rate	14.38%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	133.15
200-Day Moving Average	117.42
Relative Strength Index (RSI)	36.84
Average Volume (20 Days)	1,419

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of EUR 49.07 billion and earned 11.74 billion in profits. Earnings per share was 6.05.

Revenue	49.07B
Gross Profit	37.07B
Operating Income	15.98B
Pretax Income	13.69B
Net Income	11.74B
EBITDA	19.88B
EBIT	15.98B
Earnings Per Share (EPS)	6.05

Balance Sheet

The company has 5.98 billion in cash and 40.76 billion in debt, giving a net cash position of -34.78 billion.

Cash & Cash Equivalents	5.98B
Total Debt	40.76B
Net Cash	-34.78B
Net Cash Per Share	n/a
Equity (Book Value)	33.76B
Book Value Per Share	17.51
Working Capital	-4.13B

Cash Flow

In the last 12 months, operating cash flow was 16.63 billion and capital expenditures -1.42 billion, giving a free cash flow of 15.21 billion.

Operating Cash Flow	16.63B
Capital Expenditures	-1.42B
Depreciation & Amortization	3.84B
Net Borrowing	12.40B
Free Cash Flow	15.21B
FCF Per Share	n/a

Margins

Gross margin is 75.55%, with operating and profit margins of 32.56% and 23.92%.

Gross Margin	75.55%
Operating Margin	32.56%
Pretax Margin	27.90%
Profit Margin	23.92%
EBITDA Margin	40.51%
EBIT Margin	32.56%
FCF Margin	30.99%

Dividends & Yields

This stock pays an annual dividend of 4.10, which amounts to a dividend yield of 3.30%.

Dividend Per Share	4.10
Dividend Yield	3.30%
Dividend Growth (YoY)	17.07%
Years of Dividend Growth	4
Payout Ratio	67.67%
Buyback Yield	3.80%
Shareholder Yield	7.04%
Earnings Yield	4.96%
FCF Yield	6.42%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.27 and a Piotroski F-Score of 5.

Altman Z-Score	3.27
Piotroski F-Score	5